Cargando…

Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome

BACKGROUND: Failure of circulating monocytes for adequate cytokine production is a trait of sepsis-induced immunosuppression; however, its duration and association with final outcome are poorly understood. METHODS: We conducted a substudy of a large randomised clinical trial. Peripheral blood mononu...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonakos, Nikolaos, Tsaganos, Thomas, Oberle, Volker, Tsangaris, Iraklis, Lada, Malvina, Pistiki, Aikaterini, Machairas, Nikolaos, Souli, Maria, Bauer, Michael, Giamarellos-Bourboulis, Evangelos J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343541/
https://www.ncbi.nlm.nih.gov/pubmed/28274246
http://dx.doi.org/10.1186/s13054-017-1625-1
_version_ 1782513383514308608
author Antonakos, Nikolaos
Tsaganos, Thomas
Oberle, Volker
Tsangaris, Iraklis
Lada, Malvina
Pistiki, Aikaterini
Machairas, Nikolaos
Souli, Maria
Bauer, Michael
Giamarellos-Bourboulis, Evangelos J.
author_facet Antonakos, Nikolaos
Tsaganos, Thomas
Oberle, Volker
Tsangaris, Iraklis
Lada, Malvina
Pistiki, Aikaterini
Machairas, Nikolaos
Souli, Maria
Bauer, Michael
Giamarellos-Bourboulis, Evangelos J.
author_sort Antonakos, Nikolaos
collection PubMed
description BACKGROUND: Failure of circulating monocytes for adequate cytokine production is a trait of sepsis-induced immunosuppression; however, its duration and association with final outcome are poorly understood. METHODS: We conducted a substudy of a large randomised clinical trial. Peripheral blood mononuclear cells (PBMCs) were isolated within the first 24 h from the onset of systemic inflammatory response syndrome in 95 patients with microbiologically confirmed or clinically suspected gram-negative infections. Isolation was repeated on days 3, 7 and 10. PBMCs were stimulated for cytokine production. The study endpoints were the differences between survivors and non-survivors, the persistence of immunosuppression, and determination of admission clinical signs that can lead to early identification of the likelihood of immunosuppression. RESULTS: PBMCs of survivors produced significantly greater concentrations of tumour necrosis factor-α (TNF-α), interleukin (IL)-6, IL-8, IL-10, interferon-γ and granulocyte-macrophage colony-stimulating factor after day 3. Using ROC analysis, we found that TNF-α production less than 250 pg/ml after lipopolysaccharide stimulation on day 3 could discriminate patients from healthy control subjects; this was associated with a 5.18 OR of having an unfavourable outcome (p = 0.046). This trait persisted as long as day 10. Logistic regression analysis showed that cardiovascular failure on admission was the only independent predictor of defective TNF-α production on day 3. CONCLUSIONS: Defective TNF-α production is a major trait of sepsis-induced immunosuppression. It is associated with significant risk for unfavourable outcome and persists until day 10. Cardiovascular failure on admission is predictive of defective TNF-α production during follow-up. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01223690. Registered on 18 October 2010. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1625-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5343541
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53435412017-03-10 Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome Antonakos, Nikolaos Tsaganos, Thomas Oberle, Volker Tsangaris, Iraklis Lada, Malvina Pistiki, Aikaterini Machairas, Nikolaos Souli, Maria Bauer, Michael Giamarellos-Bourboulis, Evangelos J. Crit Care Research BACKGROUND: Failure of circulating monocytes for adequate cytokine production is a trait of sepsis-induced immunosuppression; however, its duration and association with final outcome are poorly understood. METHODS: We conducted a substudy of a large randomised clinical trial. Peripheral blood mononuclear cells (PBMCs) were isolated within the first 24 h from the onset of systemic inflammatory response syndrome in 95 patients with microbiologically confirmed or clinically suspected gram-negative infections. Isolation was repeated on days 3, 7 and 10. PBMCs were stimulated for cytokine production. The study endpoints were the differences between survivors and non-survivors, the persistence of immunosuppression, and determination of admission clinical signs that can lead to early identification of the likelihood of immunosuppression. RESULTS: PBMCs of survivors produced significantly greater concentrations of tumour necrosis factor-α (TNF-α), interleukin (IL)-6, IL-8, IL-10, interferon-γ and granulocyte-macrophage colony-stimulating factor after day 3. Using ROC analysis, we found that TNF-α production less than 250 pg/ml after lipopolysaccharide stimulation on day 3 could discriminate patients from healthy control subjects; this was associated with a 5.18 OR of having an unfavourable outcome (p = 0.046). This trait persisted as long as day 10. Logistic regression analysis showed that cardiovascular failure on admission was the only independent predictor of defective TNF-α production on day 3. CONCLUSIONS: Defective TNF-α production is a major trait of sepsis-induced immunosuppression. It is associated with significant risk for unfavourable outcome and persists until day 10. Cardiovascular failure on admission is predictive of defective TNF-α production during follow-up. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01223690. Registered on 18 October 2010. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1625-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-09 /pmc/articles/PMC5343541/ /pubmed/28274246 http://dx.doi.org/10.1186/s13054-017-1625-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Antonakos, Nikolaos
Tsaganos, Thomas
Oberle, Volker
Tsangaris, Iraklis
Lada, Malvina
Pistiki, Aikaterini
Machairas, Nikolaos
Souli, Maria
Bauer, Michael
Giamarellos-Bourboulis, Evangelos J.
Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome
title Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome
title_full Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome
title_fullStr Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome
title_full_unstemmed Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome
title_short Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome
title_sort decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343541/
https://www.ncbi.nlm.nih.gov/pubmed/28274246
http://dx.doi.org/10.1186/s13054-017-1625-1
work_keys_str_mv AT antonakosnikolaos decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome
AT tsaganosthomas decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome
AT oberlevolker decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome
AT tsangarisiraklis decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome
AT ladamalvina decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome
AT pistikiaikaterini decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome
AT machairasnikolaos decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome
AT soulimaria decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome
AT bauermichael decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome
AT giamarellosbourboulisevangelosj decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome